NCT01183312View on ClinicalTrials.gov

Flumazenil for the Treatment of Primary Hypersomnia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
HypersomniaPrimary HypersomniaIdiopathic HypersomniaNarcolepsy Without Cataplexy
Interventions
DRUG

Flumazenil

Sublingual flumazenil

Trial Locations (1)

30329

Emory Sleep Center, Atlanta

Sponsors

Collaborators (1)

Georgia Research Alliance
All Listed Sponsors
collaborator

Georgia Research Alliance

OTHER

lead

Lynn Marie Trotti

OTHER